Patents by Inventor Nouria Hernandez

Nouria Hernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith
    Patent number: 8632979
    Abstract: The present invention provides methods for determining a putative agent that treats or prevent obesity and/or obesity related diseases comprising contacting cells with the putative agent and measuring the activity and/or level of Maf1 and/or the activity and/or level of KIAA1875. The present invention also provides the agent identified by the methods herein and methods of treating or preventing obesity and/or obesity related diseases in a subject comprising administering to the subject a therapeutically effective amount of an agent that inhibits or downregulates Maf1 and/or activates or upregulates KIAA1875.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: January 21, 2014
    Assignees: Albert Einstein College of Medicine of Yeshiva University, University of Lausanne
    Inventors: Ian M. Willis, Nouria Hernandez, Wassim Hodroj
  • METHODS FOR DETERMINING AGENTS THAT TREAT OR PREVENT OBESITY AND/OR OBESITY RELATED DISEASES AND METHODS FOR TREATMENT THEREWITH
    Publication number: 20120128690
    Abstract: The present invention provides methods for determining a putative agent that treats or prevent obesity and/or obesity related diseases comprising contacting cells with the putative agent and measuring the activity and/or level of Maf1 and/or the activity and/or level of KIAA1875. The present invention also provides the agent identified by the methods herein and methods of treating or preventing obesity and/or obesity related diseases in a subject comprising administering to the subject a therapeutically effective amount of an agent that inhibits or downregulates Maf1 and/or activates or upregulates KIAA1875.
    Type: Application
    Filed: November 17, 2011
    Publication date: May 24, 2012
    Applicants: University of Lausanne, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Ian M. Willis, Nouria Hernandez, Wassim Hodroj